Especifique uma ação ou criptomoeda na barra de pesquisa para obter um resumo
Ypsomed Holding AG
YPSNYpsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for pharmaceutical and biotechnology companies. The company operates through two segments, Ypsomed Delivery Systems and Ypsomed Diabetes Care. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto injectors, and wearable injectors, as well as other smart devices. This segment offers its products under the YDS brand. The Ypsomed Diabetes Care segment sells and trades in insulin pumps, infusion sets, pen needles, blood glucose monitoring systems, accessories, and other day-to-day items for diabetics. This segment offers its products under the mylife brand name. The company offers precision turned parts; and contract manufacturing and other services. It markets its products through pharmaceutical partners, as well as through its own distribution network and independent distributors. It operates in Switzerland, Europe, North America, and internationally. Ypsomed Holding AG was founded in 1984 and is headquartered in Burgdorf, Switzerland. Address: Brunnmattstrasse 6, Burgdorf, Switzerland, 3401
Analytics
Preço Alvo de Wall Street
157.61 CHFRácio P/E
71.4286Rendimento de dividendos
0.27 %Ano atual
Ano passado
Trimestre Atual
Ultimo quarto
Ano atual
Ano passado
Trimestre Atual
Ultimo quarto
Figuras chave YPSN
Análise de Dividendos YPSN
Crescimento de dividendos em 5 anos
-53 %Crescimento contínuo
1 anoTaxa de pagamento em média de 5 anos
36 %Histórico de Dividendos YPSN
Avaliação de ações YPSN
Relatório YPSN
Acompanhe as principais métricas de cada ação em um só lugar, sem complicações
Inscreva-se no premiumResultados | 2019 | Dinâmica |